Nature Medicine, ISSN 1078-8956, 07/2017, Volume 23, Issue 7, pp. 859 - 868
Emerging evidence has linked the gut microbiome to human obesity. We performed a metagenome-wide association study and serum metabolomics profiling in a cohort...
MEDICINE, RESEARCH & EXPERIMENTAL | THETAIOTAOMICRON | RICHNESS | BIOCHEMISTRY & MOLECULAR BIOLOGY | Y GASTRIC BYPASS | MARKERS | DIET-INDUCED OBESITY | CELL BIOLOGY | MONOSODIUM GLUTAMATE | IMPACT | GLUCOSE | GENES | BARIATRIC SURGERY | Humans | Male | Dysbiosis - microbiology | Obesity - microbiology | Bacteroides thetaiotaomicron - genetics | Case-Control Studies | Young Adult | Adiposity | Adult | DNA, Bacterial - analysis | Female | Weight Gain | Bariatric Surgery | Obesity - surgery | Metabolome | Fusobacterium - genetics | Gastrectomy | Gastrointestinal Microbiome - genetics | Dysbiosis - metabolism | Obesity - metabolism | Bacteroides - genetics | Animals | Glutamic Acid - blood | Mice | Metagenome | Obesity | Usage | Microbiota (Symbiotic organisms) | Patient outcomes | Analysis | Surgery | Weight loss | Glutamate | Health aspects | Intervention | Glutamic acid | Metabolomics | Stomach | Profiling | Adipose tissue | Amino acids | Abundance | Alterations | Microorganisms | Weight control | Metabolites | Intestine | Human performance | Rodents | Weight reduction | Links | Gastrointestinal surgery | Intestinal microflora | Digestive tract
MEDICINE, RESEARCH & EXPERIMENTAL | THETAIOTAOMICRON | RICHNESS | BIOCHEMISTRY & MOLECULAR BIOLOGY | Y GASTRIC BYPASS | MARKERS | DIET-INDUCED OBESITY | CELL BIOLOGY | MONOSODIUM GLUTAMATE | IMPACT | GLUCOSE | GENES | BARIATRIC SURGERY | Humans | Male | Dysbiosis - microbiology | Obesity - microbiology | Bacteroides thetaiotaomicron - genetics | Case-Control Studies | Young Adult | Adiposity | Adult | DNA, Bacterial - analysis | Female | Weight Gain | Bariatric Surgery | Obesity - surgery | Metabolome | Fusobacterium - genetics | Gastrectomy | Gastrointestinal Microbiome - genetics | Dysbiosis - metabolism | Obesity - metabolism | Bacteroides - genetics | Animals | Glutamic Acid - blood | Mice | Metagenome | Obesity | Usage | Microbiota (Symbiotic organisms) | Patient outcomes | Analysis | Surgery | Weight loss | Glutamate | Health aspects | Intervention | Glutamic acid | Metabolomics | Stomach | Profiling | Adipose tissue | Amino acids | Abundance | Alterations | Microorganisms | Weight control | Metabolites | Intestine | Human performance | Rodents | Weight reduction | Links | Gastrointestinal surgery | Intestinal microflora | Digestive tract
Journal Article
Molecular Cancer, ISSN 1476-4598, 11/2017, Volume 16, Issue 1, pp. 169 - 14
Background: Pancreatic cancer, one of the top two most fatal cancers, is characterized by a desmoplastic reaction that creates a dense microenvironment,...
MIGRATION | INVASION | ONCOLOGY | DUCTAL ADENOCARCINOMA | PUMILIO PROTEINS | COLORECTAL-CANCER | BIOCHEMISTRY & MOLECULAR BIOLOGY | DOWN-REGULATION | PROLIFERATION | IDENTIFICATION | RENAL-CELL CARCINOMA | MIR-125A-3P | Immunohistochemistry | Care and treatment | Prognosis | Analysis | Pancreatic cancer | Metastasis | Diagnosis | Research | Binding proteins | Gene expression
MIGRATION | INVASION | ONCOLOGY | DUCTAL ADENOCARCINOMA | PUMILIO PROTEINS | COLORECTAL-CANCER | BIOCHEMISTRY & MOLECULAR BIOLOGY | DOWN-REGULATION | PROLIFERATION | IDENTIFICATION | RENAL-CELL CARCINOMA | MIR-125A-3P | Immunohistochemistry | Care and treatment | Prognosis | Analysis | Pancreatic cancer | Metastasis | Diagnosis | Research | Binding proteins | Gene expression
Journal Article
3.
Full Text
Downregulation of gas5 increases pancreatic cancer cell proliferation by regulating CDK6
Cell and Tissue Research, ISSN 0302-766X, 12/2013, Volume 354, Issue 3, pp. 891 - 896
Recent studies have revealed that long non-coding RNAs (lncRNAs) play important roles in cancer biology and that lncRNA gas5 (growth arrest-specific 5)...
Human Genetics | Biomedicine | CDK6 | lncRNA | Pancreatic cancer | Proteomics | Cell cycle | Molecular Medicine | Gas5 | BLADDER-CANCER | METASTASIS | GENOME | CELL BIOLOGY | H19 CONTRIBUTES | LONG NONCODING RNA | GROWTH-ARREST | EXPRESSION | Pancreatic Neoplasms - metabolism | Down-Regulation | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Cyclin-Dependent Kinase 6 - genetics | Gene Expression Regulation, Neoplastic | Cell Growth Processes - physiology | Pancreatic Neoplasms - genetics | Cyclin-Dependent Kinase 6 - metabolism | RNA, Long Noncoding - genetics | Cell Line, Tumor | Aged | RNA, Long Noncoding - metabolism | Development and progression | Cell growth | Gene expression | Ribonucleic acid--RNA
Human Genetics | Biomedicine | CDK6 | lncRNA | Pancreatic cancer | Proteomics | Cell cycle | Molecular Medicine | Gas5 | BLADDER-CANCER | METASTASIS | GENOME | CELL BIOLOGY | H19 CONTRIBUTES | LONG NONCODING RNA | GROWTH-ARREST | EXPRESSION | Pancreatic Neoplasms - metabolism | Down-Regulation | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Cyclin-Dependent Kinase 6 - genetics | Gene Expression Regulation, Neoplastic | Cell Growth Processes - physiology | Pancreatic Neoplasms - genetics | Cyclin-Dependent Kinase 6 - metabolism | RNA, Long Noncoding - genetics | Cell Line, Tumor | Aged | RNA, Long Noncoding - metabolism | Development and progression | Cell growth | Gene expression | Ribonucleic acid--RNA
Journal Article
Nature Genetics, ISSN 1061-4036, 2014, Volume 46, Issue 8, pp. 872 - 876
Individuals with gallbladder carcinoma (GBC), the most aggressive malignancy of the biliary tract, have a poor prognosis. Here we report the identification of...
MUTAGENESIS | BILIARY-TRACT | HUMAN CANCERS | GENOME | GENETICS & HEREDITY | Cell Line | Receptor, Epidermal Growth Factor - genetics | Humans | Middle Aged | Gallbladder Neoplasms - genetics | Male | Signal Transduction - genetics | Neoplasm Recurrence, Local - enzymology | Exome | Gallbladder Neoplasms - enzymology | Carcinoma - enzymology | HEK293 Cells | Aged, 80 and over | Cell Line, Tumor | Adult | Carcinoma - genetics | Female | Neoplasm Recurrence, Local - genetics | Aged | Mutation | High-Throughput Nucleotide Sequencing - methods | Usage | Genetic aspects | Research | Nucleotide sequencing | Tumor proteins | Health aspects | Gallbladder cancer | Risk factors | DNA sequencing | Pathogenesis | Science | Kinases | Confidence intervals | Cell growth | Mutagenesis | Rodents | Medical prognosis | Technological change | Bioinformatics | Tumors | Cancer | Index Medicus
MUTAGENESIS | BILIARY-TRACT | HUMAN CANCERS | GENOME | GENETICS & HEREDITY | Cell Line | Receptor, Epidermal Growth Factor - genetics | Humans | Middle Aged | Gallbladder Neoplasms - genetics | Male | Signal Transduction - genetics | Neoplasm Recurrence, Local - enzymology | Exome | Gallbladder Neoplasms - enzymology | Carcinoma - enzymology | HEK293 Cells | Aged, 80 and over | Cell Line, Tumor | Adult | Carcinoma - genetics | Female | Neoplasm Recurrence, Local - genetics | Aged | Mutation | High-Throughput Nucleotide Sequencing - methods | Usage | Genetic aspects | Research | Nucleotide sequencing | Tumor proteins | Health aspects | Gallbladder cancer | Risk factors | DNA sequencing | Pathogenesis | Science | Kinases | Confidence intervals | Cell growth | Mutagenesis | Rodents | Medical prognosis | Technological change | Bioinformatics | Tumors | Cancer | Index Medicus
Journal Article
BMC Cancer, ISSN 1471-2407, 02/2012, Volume 12, Issue 1, pp. 57 - 57
Background: Toll-like receptors (TLR) are key innate immunity receptors participating in an immune response. Growing evidence suggests that mutations of...
CELLS | ONCOLOGY | GASTRIC-CANCER | CHRONIC HEPATITIS-B | SILENCE | GROWTH | RISK | TLR | GENE POLYMORPHISMS | EXPRESSION | Haplotypes | Genetic Predisposition to Disease - genetics | Toll-Like Receptor 2 - genetics | Liver Neoplasms - genetics | Humans | Middle Aged | Male | Case-Control Studies | Linkage Disequilibrium | Young Adult | Carcinoma, Hepatocellular - genetics | Adolescent | Polymerase Chain Reaction | Aged, 80 and over | Polymorphism, Single Nucleotide - genetics | Adult | Female | Aged | Physiological aspects | Genetic aspects | Hepatoma | Research | Single nucleotide polymorphisms | TLR2
CELLS | ONCOLOGY | GASTRIC-CANCER | CHRONIC HEPATITIS-B | SILENCE | GROWTH | RISK | TLR | GENE POLYMORPHISMS | EXPRESSION | Haplotypes | Genetic Predisposition to Disease - genetics | Toll-Like Receptor 2 - genetics | Liver Neoplasms - genetics | Humans | Middle Aged | Male | Case-Control Studies | Linkage Disequilibrium | Young Adult | Carcinoma, Hepatocellular - genetics | Adolescent | Polymerase Chain Reaction | Aged, 80 and over | Polymorphism, Single Nucleotide - genetics | Adult | Female | Aged | Physiological aspects | Genetic aspects | Hepatoma | Research | Single nucleotide polymorphisms | TLR2
Journal Article
Medical science monitor : international medical journal of experimental and clinical research, ISSN 1643-3750, 03/2019, Volume 25, pp. 2009 - 2015
BACKGROUND Hypoxia is an important feature of solid tumors and related to a perturbed blood supply in pathophysiologies. The aim of our research was to analyze...
Oligonucleotide Array Sequence Analysis | Gene Expression Regulation - genetics | Colorectal Neoplasms - genetics | Humans | RNA, Messenger - genetics | RNA, Messenger - analysis | Gene Expression Profiling - methods | RNA, Long Noncoding - genetics | Transcriptome - genetics | RNA, Messenger - metabolism | Sequence Analysis, RNA - methods | Tumor Hypoxia - genetics | RNA, Long Noncoding - analysis | Hypoxia - genetics | China | Angiogenesis Modulating Agents - metabolism | Cell Line, Tumor | RNA, Long Noncoding - metabolism | Gene Ontology | Index Medicus
Oligonucleotide Array Sequence Analysis | Gene Expression Regulation - genetics | Colorectal Neoplasms - genetics | Humans | RNA, Messenger - genetics | RNA, Messenger - analysis | Gene Expression Profiling - methods | RNA, Long Noncoding - genetics | Transcriptome - genetics | RNA, Messenger - metabolism | Sequence Analysis, RNA - methods | Tumor Hypoxia - genetics | RNA, Long Noncoding - analysis | Hypoxia - genetics | China | Angiogenesis Modulating Agents - metabolism | Cell Line, Tumor | RNA, Long Noncoding - metabolism | Gene Ontology | Index Medicus
Journal Article
Molecular Oncology, ISSN 1574-7891, 04/2018, Volume 12, Issue 4, pp. 529 - 544
As an established anticancer drug, gemcitabine (GEM) is an effective systemic treatment for advanced pancreatic cancer (PC). However, little is known about the...
chloroquine | lysosomal membrane permeabilization | apoptosis | gemcitabine | reactive oxygen species | OXIDATIVE STRESS | ADENOCARCINOMA | DEATH | AUTOPHAGY | COMBINATION | CHEMOTHERAPY | HEPATOCELLULAR-CARCINOMA | ONCOLOGY | DOUBLE-EDGED-SWORD | ACCUMULATION | Pancreatic Neoplasms - metabolism | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Humans | Pancreatic Neoplasms - pathology | Deoxycytidine - pharmacology | Male | Neoplasm Proteins - metabolism | Pancreatic Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Chloroquine - pharmacology | Animals | Lysosomes - metabolism | Mice, Nude | Cell Line, Tumor | Lysosomes - pathology | Mice | Mice, Inbred BALB C | Deoxycytidine - analogs & derivatives
chloroquine | lysosomal membrane permeabilization | apoptosis | gemcitabine | reactive oxygen species | OXIDATIVE STRESS | ADENOCARCINOMA | DEATH | AUTOPHAGY | COMBINATION | CHEMOTHERAPY | HEPATOCELLULAR-CARCINOMA | ONCOLOGY | DOUBLE-EDGED-SWORD | ACCUMULATION | Pancreatic Neoplasms - metabolism | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Humans | Pancreatic Neoplasms - pathology | Deoxycytidine - pharmacology | Male | Neoplasm Proteins - metabolism | Pancreatic Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Chloroquine - pharmacology | Animals | Lysosomes - metabolism | Mice, Nude | Cell Line, Tumor | Lysosomes - pathology | Mice | Mice, Inbred BALB C | Deoxycytidine - analogs & derivatives
Journal Article
8.
Full Text
Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 1, p. e15640
Cholangiocarcinoma, also known as bile duct cancer, is the second most common primary hepatic carcinoma with a median survival of less than 2 years. The...
PATHOGENESIS | GLIOBLASTOMA | PROTEIN | PHOSPHORYLATION | PATHWAY | LIVER-REGENERATION | GENES | BIOLOGY | CANCER | EXPRESSION | Proto-Oncogene Proteins - metabolism | Immunoassay | Oncogene Proteins, Fusion - metabolism | Phosphorylation | Signal Transduction | Protein-Tyrosine Kinases - metabolism | Humans | Proto-Oncogene Proteins - genetics | Bile Duct Neoplasms - enzymology | Protein-Tyrosine Kinases - genetics | Animals | Mice, Nude | Oncogene Proteins, Fusion - genetics | Cell Line, Tumor | Bile Ducts, Intrahepatic | Mice | Protein-Tyrosine Kinases - analysis | Cholangiocarcinoma - enzymology | Surveys | Proteins | Tyrosine | Lung cancer | Phenols | Development and progression | Health aspects | Phosphotransferases | Heart surgery | Pathogenesis | Glioblastoma | Identification | Kinases | Phosphatase | Liver cancer | Signal transduction | Rodents | Protein-tyrosine kinase | Chromosomes | Cholangiocarcinoma | EphA2 protein | Epidermal growth factor receptors | Mass spectroscopy | Patients | Bile duct | Medicine | Signaling | Molecular modelling | Scientific imaging | Diagnostic systems | Mass spectrometry | Cancer | Tumors
PATHOGENESIS | GLIOBLASTOMA | PROTEIN | PHOSPHORYLATION | PATHWAY | LIVER-REGENERATION | GENES | BIOLOGY | CANCER | EXPRESSION | Proto-Oncogene Proteins - metabolism | Immunoassay | Oncogene Proteins, Fusion - metabolism | Phosphorylation | Signal Transduction | Protein-Tyrosine Kinases - metabolism | Humans | Proto-Oncogene Proteins - genetics | Bile Duct Neoplasms - enzymology | Protein-Tyrosine Kinases - genetics | Animals | Mice, Nude | Oncogene Proteins, Fusion - genetics | Cell Line, Tumor | Bile Ducts, Intrahepatic | Mice | Protein-Tyrosine Kinases - analysis | Cholangiocarcinoma - enzymology | Surveys | Proteins | Tyrosine | Lung cancer | Phenols | Development and progression | Health aspects | Phosphotransferases | Heart surgery | Pathogenesis | Glioblastoma | Identification | Kinases | Phosphatase | Liver cancer | Signal transduction | Rodents | Protein-tyrosine kinase | Chromosomes | Cholangiocarcinoma | EphA2 protein | Epidermal growth factor receptors | Mass spectroscopy | Patients | Bile duct | Medicine | Signaling | Molecular modelling | Scientific imaging | Diagnostic systems | Mass spectrometry | Cancer | Tumors
Journal Article
Cancer Letters, ISSN 0304-3835, 01/2018, Volume 412, pp. 59 - 68
The members of the miR-17-92 cluster are upregulated in various cancers and function as a cluster of oncogenic miRNA. Our study characterized a new function of...
RBL2 | miR-17-5p | E2F4 | Pancreatic cancer | Cell cycle | RB2/P130 | TRANSCRIPTIONAL REPRESSION | RETINOBLASTOMA PROTEIN | GENE | ONCOLOGY | PRB2/P130 | E2F | TUMOR-SUPPRESSOR | DIFFERENTIATION | CLUSTER | EXPRESSION | E2F4 Transcription Factor - genetics | Adenocarcinoma - pathology | Cell Proliferation | Retinoblastoma-Like Protein p130 - physiology | Cell Cycle | E2F4 Transcription Factor - physiology | Humans | Pancreatic Neoplasms - pathology | Cell Line, Tumor | MicroRNAs - physiology | Carcinoma, Pancreatic Ductal - pathology | Retinoblastoma-Like Protein p130 - genetics | Analysis | Cell proliferation | Adenocarcinoma | Repressing | Transcription factors | Cloning | MiRNA | Genomes | Gene expression | Cell adhesion & migration | Proteins | E2F protein | Plasmids | Medical prognosis | Clusters | Tumor suppressor genes | Retinoblastoma | Deoxyribonucleic acid--DNA | Cancer | Tumors
RBL2 | miR-17-5p | E2F4 | Pancreatic cancer | Cell cycle | RB2/P130 | TRANSCRIPTIONAL REPRESSION | RETINOBLASTOMA PROTEIN | GENE | ONCOLOGY | PRB2/P130 | E2F | TUMOR-SUPPRESSOR | DIFFERENTIATION | CLUSTER | EXPRESSION | E2F4 Transcription Factor - genetics | Adenocarcinoma - pathology | Cell Proliferation | Retinoblastoma-Like Protein p130 - physiology | Cell Cycle | E2F4 Transcription Factor - physiology | Humans | Pancreatic Neoplasms - pathology | Cell Line, Tumor | MicroRNAs - physiology | Carcinoma, Pancreatic Ductal - pathology | Retinoblastoma-Like Protein p130 - genetics | Analysis | Cell proliferation | Adenocarcinoma | Repressing | Transcription factors | Cloning | MiRNA | Genomes | Gene expression | Cell adhesion & migration | Proteins | E2F protein | Plasmids | Medical prognosis | Clusters | Tumor suppressor genes | Retinoblastoma | Deoxyribonucleic acid--DNA | Cancer | Tumors
Journal Article
Cancer Letters, ISSN 0304-3835, 06/2019, Volume 452, pp. 270 - 270
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e15730 - e15730
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2014, Volume 9, Issue 12, p. e115577
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. Despite progress in diagnostics and treatment of HCC, its...
OVEREXPRESSION | HEPATOCELLULAR-CARCINOMA | CANCER INVASION | METASTASIS | ANGIOGENESIS | POOR-PROGNOSIS | MULTIDISCIPLINARY SCIENCES | DOWN-REGULATION | MICRORNAS | EXPRESSION | SNAIL | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Matrix Metalloproteinase 14 - biosynthesis | Carcinoma, Hepatocellular - genetics | Adult | Female | Liver Neoplasms - pathology | Neoplasm Proteins - genetics | Liver Neoplasms - genetics | Neoplasm Invasiveness | Neoplasm Proteins - biosynthesis | MicroRNAs - biosynthesis | Hep G2 Cells | Gene Expression Regulation, Enzymologic | RNA, Neoplasm - biosynthesis | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - metabolism | Matrix Metalloproteinase 14 - genetics | RNA, Neoplasm - genetics | Aged | MicroRNAs - genetics | Carcinoma, Hepatocellular - metabolism | Cell Movement | Target recognition | MiRNA | Hepatocellular carcinoma | Chromosome 5 | Hepatoma | Matrix metalloproteinase | Gene expression | Tissues | Kinases | Ovarian cancer | Cell adhesion & migration | Metastases | Liver cancer | Molecular modelling | DNA microarrays | Rodents | Metalloproteinase | Inhibition | Cell migration | Cancer
OVEREXPRESSION | HEPATOCELLULAR-CARCINOMA | CANCER INVASION | METASTASIS | ANGIOGENESIS | POOR-PROGNOSIS | MULTIDISCIPLINARY SCIENCES | DOWN-REGULATION | MICRORNAS | EXPRESSION | SNAIL | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Matrix Metalloproteinase 14 - biosynthesis | Carcinoma, Hepatocellular - genetics | Adult | Female | Liver Neoplasms - pathology | Neoplasm Proteins - genetics | Liver Neoplasms - genetics | Neoplasm Invasiveness | Neoplasm Proteins - biosynthesis | MicroRNAs - biosynthesis | Hep G2 Cells | Gene Expression Regulation, Enzymologic | RNA, Neoplasm - biosynthesis | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - metabolism | Matrix Metalloproteinase 14 - genetics | RNA, Neoplasm - genetics | Aged | MicroRNAs - genetics | Carcinoma, Hepatocellular - metabolism | Cell Movement | Target recognition | MiRNA | Hepatocellular carcinoma | Chromosome 5 | Hepatoma | Matrix metalloproteinase | Gene expression | Tissues | Kinases | Ovarian cancer | Cell adhesion & migration | Metastases | Liver cancer | Molecular modelling | DNA microarrays | Rodents | Metalloproteinase | Inhibition | Cell migration | Cancer
Journal Article
Cellular Physiology and Biochemistry, ISSN 1015-8987, 12/2017, Volume 44, Issue 4, pp. 1471 - 1484
Background/Aims: Anaplastic thyroid carcinoma (ATC) is one of the most lethal human malignancies, and there is no efficient method to slow its process....
Original Paper | Apatinib | GSK3β | Akt | Angiogenin | Agiogenesis | Anaplastic thyroid carcinoma | Human Umbilical Vein Endothelial Cells | Neovascularization, Physiologic - drug effects | Apoptosis - drug effects | Humans | Male | Transplantation, Heterologous | Recombinant Proteins - biosynthesis | Antineoplastic Agents - toxicity | Thyroid Carcinoma, Anaplastic - metabolism | Proto-Oncogene Proteins c-akt - metabolism | Ribonuclease, Pancreatic - genetics | Glycogen Synthase Kinase 3 beta - antagonists & inhibitors | Recombinant Proteins - genetics | Recombinant Proteins - pharmacology | Glycogen Synthase Kinase 3 beta - metabolism | Cell Movement - drug effects | Animals | Pyridines - toxicity | Ribonuclease, Pancreatic - metabolism | Signal Transduction - drug effects | Mice, Nude | Cell Line, Tumor | Thyroid Carcinoma, Anaplastic - pathology | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | G1 Phase Cell Cycle Checkpoints - drug effects | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Thyroid Neoplasms - metabolism | Thyroid Neoplasms - pathology | Angiogenesis | Thyroid cancer | Cold | Cell cycle | Cytotoxicity | Metastasis | Medical screening | Kinases | Vascular endothelial growth factor | Cancer therapies | Apoptosis
Original Paper | Apatinib | GSK3β | Akt | Angiogenin | Agiogenesis | Anaplastic thyroid carcinoma | Human Umbilical Vein Endothelial Cells | Neovascularization, Physiologic - drug effects | Apoptosis - drug effects | Humans | Male | Transplantation, Heterologous | Recombinant Proteins - biosynthesis | Antineoplastic Agents - toxicity | Thyroid Carcinoma, Anaplastic - metabolism | Proto-Oncogene Proteins c-akt - metabolism | Ribonuclease, Pancreatic - genetics | Glycogen Synthase Kinase 3 beta - antagonists & inhibitors | Recombinant Proteins - genetics | Recombinant Proteins - pharmacology | Glycogen Synthase Kinase 3 beta - metabolism | Cell Movement - drug effects | Animals | Pyridines - toxicity | Ribonuclease, Pancreatic - metabolism | Signal Transduction - drug effects | Mice, Nude | Cell Line, Tumor | Thyroid Carcinoma, Anaplastic - pathology | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | G1 Phase Cell Cycle Checkpoints - drug effects | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Thyroid Neoplasms - metabolism | Thyroid Neoplasms - pathology | Angiogenesis | Thyroid cancer | Cold | Cell cycle | Cytotoxicity | Metastasis | Medical screening | Kinases | Vascular endothelial growth factor | Cancer therapies | Apoptosis
Journal Article
Surgery, ISSN 0039-6060, 10/2019
Journal Article
The Journal of Pathology, ISSN 0022-3417, 10/2017, Volume 243, Issue 2, pp. 155 - 159
In pancreatic cancer, pancreatic adenosquamous carcinoma (PASC) containing both ductal adenocarcinoma and squamous carcinoma in the same tumour represents ∼4%...
mixed cancer | pancreatic adenosquamous carcinoma (PASC) | 3p loss | TP53 | ONCOLOGY | STATISTICS | PATHOLOGY | ABERRATIONS | CANCER | Humans | Pancreatic Neoplasms - genetics | Carcinoma, Adenosquamous - genetics | Mutation - genetics | Neoplasm Proteins - genetics | Genes, Neoplasm - genetics | Genome, Human - genetics | Yuan (China) | Squamous cell carcinoma | Gene mutations | Analysis | Pancreatic cancer | Oncology, Experimental | Genomics | Genetic aspects | Research | Tumor proteins | Cancer | Adenocarcinoma | Pancreatic carcinoma | p53 Protein | Genomes | Adenosquamous | Mutation | Pancreas | Tumors
mixed cancer | pancreatic adenosquamous carcinoma (PASC) | 3p loss | TP53 | ONCOLOGY | STATISTICS | PATHOLOGY | ABERRATIONS | CANCER | Humans | Pancreatic Neoplasms - genetics | Carcinoma, Adenosquamous - genetics | Mutation - genetics | Neoplasm Proteins - genetics | Genes, Neoplasm - genetics | Genome, Human - genetics | Yuan (China) | Squamous cell carcinoma | Gene mutations | Analysis | Pancreatic cancer | Oncology, Experimental | Genomics | Genetic aspects | Research | Tumor proteins | Cancer | Adenocarcinoma | Pancreatic carcinoma | p53 Protein | Genomes | Adenosquamous | Mutation | Pancreas | Tumors
Journal Article